Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.969 EUR | +1.81% | +4.01% | -13.89% |
Apr. 24 | CapMan to Sell Special Transport Group Havator | MT |
Apr. 15 | Faron Pharmaceuticals reappoints former finance chief on interim basis | AN |
Sales 2024 * | 70.3M 75.41M | Sales 2025 * | 79.47M 85.25M | Capitalization | 341M 366M |
---|---|---|---|---|---|
Net income 2024 * | 22M 23.6M | Net income 2025 * | 33M 35.4M | EV / Sales 2024 * | 5.57 x |
Net Debt 2024 * | 50.17M 53.81M | Net Debt 2025 * | 37.83M 40.58M | EV / Sales 2025 * | 4.77 x |
P/E ratio 2024 * |
14.8
x | P/E ratio 2025 * |
9.85
x | Employees | 200 |
Yield 2024 * |
5.86% | Yield 2025 * |
7.93% | Free-Float | 65.89% |
Latest transcript on CapMan Oyj
1 day | +1.24% | ||
1 week | +2.64% | ||
Current month | +0.52% | ||
1 month | +0.72% | ||
3 months | -14.46% | ||
6 months | -5.76% | ||
Current year | -15.02% |
Managers | Title | Age | Since |
---|---|---|---|
Pia Kåll
CEO | Chief Executive Officer | 44 | 23-03-14 |
Joakim Frimodig
CHM | Chairman | 46 | 15-12-31 |
Atte Rissanen
DFI | Director of Finance/CFO | 37 | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Johan Bygge
BRD | Director/Board Member | 68 | 21-03-16 |
Director/Board Member | 67 | 19-03-12 | |
Director/Board Member | 58 | 93-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.972 | +1.96% | 39 645 |
24-04-25 | 1.934 | -0.21% | 157,959 |
24-04-24 | 1.938 | +0.62% | 82,116 |
24-04-23 | 1.926 | +0.73% | 77,449 |
24-04-22 | 1.912 | +0.84% | 52,029 |
Delayed Quote Nasdaq Helsinki, April 26, 2024 at 03:22 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.02% | 366M | |
-0.82% | 33.6B | |
+4.14% | 31.53B | |
+6.71% | 5.55B | |
-0.62% | 3.09B | |
+12.78% | 2.92B | |
+19.40% | 2.86B | |
-19.56% | 2.18B | |
+4.52% | 1.24B | |
-2.55% | 1.05B |
- Stock Market
- Equities
- CAPMAN Stock